'We'll create a scientific powerhouse': Pfizer defends AstraZeneca takeover bid

Pfizer has defended its campaign to snap up AstraZeneca in Britain’s biggest foreign takeover claiming the £63 billion deal would create a “scientific powerhouse”.

The US drugmaker also hit back at politicians’ claims that its statement on UK jobs was not "watertight" as bosses from the two companies prepare to be grilled in Parliament tomorrow and on Wednesday.

In its select committee submissions, Pfizer said of its pledge to keep a fifth of the combined company’s research and development workforce in the UK for five years that although "we had no obligation to make these [jobs] commitments we were willing to do so because we support the opportunity to strengthen the UK life sciences industry.

"We understand fully that they would be binding as a matter of English law."

There are fears that a takeover could see Pfizer axe thousands of jobs, and top scientists — including the provost of University College, London — have warned that medical research in the UK could be “nullified” by the deal.

But Pfizer’s president of research, Mikael Dolsten, who will be giving evidence before the science and Technology select committee on Wednesday, made the unusual move of writing a newspaper column on why the potential takeover “would benefit patients around the world and strengthen the UK’s life sciences industry”.

Writing in the Evening Standard, Dolsten, who joined Pfizer as part of its $68 billion (£40 billion) acquisition of Wyeth in 2009, wrote that as a result he can "speak from personal experience on this subject".

"[The Wyeth deal] provoked similar concerns about the impact of a big merger on scientific progress."

Dolsten claimed the US Viagra-maker has “great respect” for AstraZeneca and its heritage but a merged business would be “better placed to meet society’s demand for the faster and more cost-effective delivery of medicines”.

His attempt to woo Astra’s investors, UK politicians and this country’s scientific community comes despite no firm offer being on the table from Pfizer. AstraZeneca rejected its most recent approach.

Pfizer points out: "AstraZeneca faces difficult challenges [such as] looming patent expiries," in its select committee submissions, but does not mention its own patent cliff, with Pfizer blockbusters including cholesterol treatment Lipitor facing generic competition.

Ian Read, Pfizer’s chief executive, has recorded four videos aiming at winning support for the deal, which he claimed would be a "win win" for investors and science.

AstraZeneca chief Pascal Soriot told The Independent that AstraZeneca was healthier as an independent medicine maker: "We are creating and investing in new drugs which we believe will transform how we tackle diseases and change patients’ lives."

Start your day with The Independent, sign up for daily news emails
News
ebookA unique anthology of reporting and analysis of a crucial period of history
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Guru Careers: Pricing Analyst

£30 - 35k: Guru Careers: We are seeking a Pricing Analyst to join a leading e-...

SThree: Trainee Recruitment Consultant

£20000 - £25000 per annum + OTE £45K YR1: SThree: At SThree, we like to be dif...

SThree: Trainee Recruitment Consultant

£20000 - £25000 per annum + competitive: SThree: Did you know? SThree is a mul...

Guru Careers: C# Project Team Lead

£55 - 65k (DOE): Guru Careers: A unique opportunity for a permanent C# Develop...

Day In a Page

Blundering Tony Blair quits as Middle East peace envoy – only Israel will miss him

Blundering Blair quits as Middle East peace envoy – only Israel will miss him

For Arabs – and for Britons who lost their loved ones in his shambolic war in Iraq – his appointment was an insult, says Robert Fisk
Fifa corruption arrests: All hail the Feds for riding to football's rescue

Fifa corruption arrests

All hail the Feds for riding to football's rescue, says Ian Herbert
Isis in Syria: The Kurdish enclave still resisting the tyranny of President Assad and militant fighters

The Kurdish enclave still resisting the tyranny of Assad and Isis

In Syrian Kurdish cantons along the Turkish border, the progressive aims of the 2011 uprising are being enacted despite the war. Patrick Cockburn returns to Amuda
How I survived Cambodia's Killing Fields: Acclaimed surgeon SreyRam Kuy celebrates her mother's determination to escape the US

How I survived Cambodia's Killing Fields

Acclaimed surgeon SreyRam Kuy celebrates her mother's determination to escape to the US
Stephen Mangan interview: From posh buffoon to pregnant dad, the actor has quite a range

How Stephen Mangan got his range

Posh buffoon, hapless writer, pregnant dad - Mangan is certainly a versatile actor
The ZX Spectrum has been crowd-funded back into play - with some 21st-century tweaks

The ZX Spectrum is back

The ZX Spectrum was the original - and for some players, still the best. David Crookes meets the fans who've kept the games' flames lit
Grace of Monaco film panned: even the screenwriter pours scorn on biopic starring Nicole Kidman

Even the screenwriter pours scorn on Grace of Monaco biopic

The critics had a field day after last year's premiere, but the savaging goes on
Menstrual Hygiene Day: The strange ideas people used to believe about periods

Menstrual Hygiene Day: The strange ideas people once had about periods

If one was missed, vomiting blood was seen as a viable alternative
The best work perks: From free travel cards to making dreams come true (really)

The quirks of work perks

From free travel cards to making dreams come true (really)
Is bridge the latest twee pastime to get hip?

Is bridge becoming hip?

The number of young players has trebled in the past year. Gillian Orr discovers if this old game has new tricks
Long author-lists on research papers are threatening the academic work system

The rise of 'hyperauthorship'

Now that academic papers are written by thousands (yes, thousands) of contributors, it's getting hard to tell workers from shirkers
The rise of Lego Clubs: How toys are helping children struggling with social interaction to build better relationships

The rise of Lego Clubs

How toys are helping children struggling with social interaction to build better relationships
5 best running glasses

On your marks: 5 best running glasses

Whether you’re pounding pavements, parks or hill passes, keep your eyes protected in all weathers
Joe Root: 'Ben Stokes gives everything – he’s rubbing off on us all'

'Ben Stokes gives everything – he’s rubbing off on us all'

Joe Root says the England dressing room is a happy place again – and Stokes is the catalyst
Raif Badawi: Wife pleads for fresh EU help as Saudi blogger's health worsens

Please save my husband

As the health of blogger Raif Badawi worsens in prison, his wife urges EU governments to put pressure on the Saudi Arabian royal family to allow her husband to join his family in Canada